Search Results 1421-1430 of 17756 for monoclonal antibody

  1. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

    History of severe allergic or anaphylactic reaction to monoclonal antibody therapy. Confirmed diagnosis of progressive multifocal leukoencephalopathy ...

  2. mRNA transfection improves CTL response in immunotherapy - Mayo Clinic

    In a 2022 study, Mayo Clinic researchers found that by transfecting cytotoxic CD8+ T cells with mRNA of natural killer cells they can improve response in ...

  3. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

    Received monoclonal antibodies or had major surgery within 30 days of the first dose of AP26113 (Day 1, Cycle 1). Have been diagnosed with another primary ...

  4. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    Prior anti-cancer monoclonal antibody (mAb) therapy for direct anti-neoplastic treatment within 4 weeks prior to study Day 1; Prior chemotherapy, targeted ...

  5. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

    Prior anti-cancer monoclonal antibody (mAb) for direct anti-neoplastic treatment within 4 weeks prior to study Day 1 or who has not recovered from adverse ...

  6. Repeat Renal Biopsies in Proteinuric Patients with Membranous Nephropathy Following Therapy - Mayo Clinic

    The purpose of this study is to evaluate the role of an antibody, called anti-PLA2R, in detecting disease in patients with membranous nephropathy (MN) who ...

  7. Minnesota - Mayo Clinic News Network

    ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  9. A Study of the Efficacy and Safety of Belimumab Compared to Placebo in Adults With Systemic Sclerosis Associated Interstitial Lung Disease - Mayo Clinic

    Anticentromere antibody negative on central test at screening. 7. Evidence ... Treatment with biologic agents, such as intravenous immunoglobulin or monoclonal

  10. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... antibodies against the study drug (which could make the drug less effective or could lead to side effects) and its combinations. A Study to Assess ...